 Secondary aims: 1 To evaluate the maintenance of intervention effects on adherence 6 months post-intervention; and 2 To assess treatment effects on components of the metabolic syndrome waist circumference, blood pressure, lipid level, and fasting plasma glucoseHbA1C. 